This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.
Oncodesign received the first milestone payment in February 2020 as part of the collaboration. ... All told, Servier could pay up to 320m in milestone payments to Oncodesign, as well as royalties on potential future sales.
As a result of hitting the first milestone of the programme, Oncodesign receives a success payment of 1m. ... The collaboration works perfectly and both teams are up to the challenges,” said Philippe Genne, CEO and founder of Oncodesign.
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over
Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...